- Business activity
Center for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals – CERAD
The CERAD investment consists of the design, construction, commissioning and handover of a finished building with a gross volume of 11,800 m³ and a height of 12 m. The planned facility will be equipped with a full range of sanitary, electric, low-voltage installations, HVAC, BMS / ERMS automation, fire protection, LAN . As part of the investment, there are plans of building and installation of a new electric transformer substation, the generator, as well as the refrigeration unit. The investment include construction of a room for technical gases. The project involves rebuilding of the roads infrastructure as well as creation of new parking and maneuvering areas.
The significant part of the project is the supply of equipment and a technological laboratories - including cyclotron bunker, Line¹²³ , SPECT line, PET line, Metalic line, R&D line and delivery and installation of a cyclotron - a device for accelerating protons and alpha particles up to 30 MeV energy and deutrons for 15 MeV energy,The completion of the Contract concluded between CP OK2 and the National Center for Nuclear Research is planned for the end of 2020.
The value of the Project is over 117 million.
|Project name||Center for Design and Synthesis of Molecularly Targeted Radiopharmaceuticals – CERAD|
|Type of project||Research Center|
|Client||National Center for Nuclear Research Radioisotope Center POLATOM|
|Duration||2017 - 2020|